Lysosomal degradation of CD44 mediates ceramide nanoliposome-induced anoikis and diminished extravasation in metastatic carcinoma cells

  • Jeremy K. Haakenson
  • , Andrei V. Khokhlatchev
  • , Younhee J. Choi
  • , Samuel S. Linton
  • , Pu Zhang
  • , Peter M. Zaki
  • , Changliang Fu
  • , Timothy K. Cooper
  • , Andrea Manni
  • , Junjia Zhu
  • , Todd E. Fox
  • , Cheng Dong
  • , Mark Kester

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Background: Even though ceramide selectively induces apoptosis in multiple cancer models, the mechanisms by which ceramide limits cancer metastasis are unknown. Results: The ceramide nanoliposome (CNL) inhibits cancer cell metastasis by inducing anoikis and inhibiting extravasation via lysosomal degradation of CD44. Conclusion: Ceramide reduces the metastatic potential of multiple cancer cell models. Significance: CNL may have therapeutic utility in preventing and treating metastatic cancers.

Original languageEnglish (US)
Pages (from-to)8632-8643
Number of pages12
JournalJournal of Biological Chemistry
Volume290
Issue number13
DOIs
StatePublished - Mar 27 2015

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Lysosomal degradation of CD44 mediates ceramide nanoliposome-induced anoikis and diminished extravasation in metastatic carcinoma cells'. Together they form a unique fingerprint.

Cite this